Integra Lifesciences Holdings's Cash & cash equivalent grew by 13.81 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Integra Lifesciences Holdings's Quick Ratio to 0.95, Quick Ratio remained below Integra Lifesciences Holdings Corp average.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Quick Ratio than Integra Lifesciences Holdings in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 0 to 2141.

Explain Quick Ratio?
How much Cash & cash equivalents IART�s has?
What are IART�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/IART/financial-strength

https://api.csimarket.com/api/v1/companies/IART/fundamentals

https://api.csimarket.com/api/v1/companies/IART/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

IART Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	-2.92 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	16.44 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.95	Subscribe	Subscribe	Subscribe	Subscribe
IART's Total Ranking	# 2141	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-0.57 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	13.81 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 117
Healthcare Sector	# 664
Overall Market	# 2141

Quick Ratio Statistics
High	Average	Low
2.38	0.96	0.27
(Mar 31 2024)		(Jun 30 2025)

Financial Statements
Integra Lifesciences Holdings's Current Liabilities	$ 329 Millions	Visit IART's Balance sheet
Integra Lifesciences Holdings's Cash & cash equivalent	$ 312 Millions	Visit IART's Balance sheet
Source of IART's Sales		Visit IART's Sales by Geography

Cumulative Integra Lifesciences Holdings's Quick Ratio

IART's Quick Ratio for the trailling 12 Months

IART Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-53.78 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	4.39 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.78	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 2130	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-0.68 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	4.11 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to IART Financial Strength Comparisons >> Go to Compare IART Quick Ratio to its Competitors

On the trailing twelve months basis IART Cash & cash equivalent increased by 16.44 % in Q3 2026 year on year, while Current Liabilities decreased to $329 millions, this led to increase in in Integra Lifesciences Holdings's Quick Ratio to 0.78, Quick Ratio remained below IART average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 204 other companies have achieved higher Quick Ratio than Integra Lifesciences Holdings. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 0 to 4021.

Explain Quick Ratio?
How much Cash & cash equivalents IART�s has?
What are IART�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 205
Healthcare Sector	# 901
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.5	0.87	0.25
(Sep 30 2022)		(Jun 30 2025)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Pulmonx Corporation	2.57	$ 53.245 Millions	$ 20.739 Millions
Beta Bionics Inc	2.48	$ 81.551 Millions	$ 32.836 Millions
Irhythm Holdings Inc	2.46	$ 560.719 Millions	$ 228.025 Millions
Genedx Holdings Corp	2.38	$ 170.118 Millions	$ 71.403 Millions
Apyx Medical Corp	2.37	$ 25.777 Millions	$ 10.870 Millions
Atricure Inc	2.23	$ 187.031 Millions	$ 83.972 Millions
Vivani Medical Inc	2.22	$ 14.591 Millions	$ 6.585 Millions
Electromed Inc	2.19	$ 15.875 Millions	$ 7.261 Millions
Inspire Medical Systems inc	1.96	$ 190.803 Millions	$ 97.438 Millions
Aethlon Medical Inc	1.91	$ 6.487 Millions	$ 3.403 Millions
Merit Medical Systems Inc	1.90	$ 503.551 Millions	$ 265.083 Millions
Nephros Inc	1.89	$ 4.546 Millions	$ 2.409 Millions
Fractyl Health Inc	1.82	$ 31.515 Millions	$ 17.345 Millions
Warby Parker Inc	1.77	$ 287.914 Millions	$ 162.226 Millions
Anika Therapeutics Inc	1.68	$ 44.957 Millions	$ 26.725 Millions
EBR Systems, Inc.	1.63	$ 85.415 Millions	$ 52.539 Millions
Intuitive Surgical Inc	1.60	$ 4,042.500 Millions	$ 2,533.000 Millions
Tactile Systems Technology Inc	1.58	$ 75.110 Millions	$ 47.499 Millions
Edap Tms Sa	1.56	$ 56.269 Millions	$ 36.070 Millions
Neuraxis Inc	1.55	$ 4.477 Millions	$ 2.888 Millions
Envista Holdings Corporation	1.42	$ 1,158.800 Millions	$ 816.300 Millions
Inogen Inc	1.38	$ 96.840 Millions	$ 70.265 Millions
Intelligent Bio Solutions Inc	1.30	$ 5.930 Millions	$ 4.578 Millions
Si bone inc	1.20	$ 35.460 Millions	$ 29.619 Millions
Medline Inc	1.12	$ 3,608.000 Millions	$ 3,211.000 Millions
Pro dex Inc	1.10	$ 14.219 Millions	$ 12.884 Millions
Sanara Medtech Inc	1.09	$ 17.788 Millions	$ 16.282 Millions
Penumbra Inc	1.09	$ 254.282 Millions	$ 233.810 Millions
Koru Medical Systems Inc	1.08	$ 7.364 Millions	$ 6.792 Millions
Establishment Labs Holdings Inc	1.06	$ 75.812 Millions	$ 71.611 Millions

Date modified: 2026-10-24T06:54:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.